KALA BIO (KALA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

KALA KALA BIO

Watchlist

6.7600
-0.0700-1.02%

Close Jul 19 16:00 ET

7.0500
+0.2900+4.29%

Pre 07:05 ET

30.14MMarket Cap-464P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Baker Bros. Advisors LP Reports 19.99% Stake in KALA BIO Inc as of June 26- SEC Filing
ReutersJun 28 16:13 ET
KALA Bio KALA Private Placement; Tonix Pharmaceuticals TNXP Offering
BioPharmCatalystJun 27 14:26 ET
Top Midday Gainers
NLS Pharmaceutics (NLSP) said Thursday that preclinical results from in vitro studies targeting alpha-synuclein, specifically the A53T mutation, showed the compounds' potential to treat Parkinson's di
MT NewswiresJun 27 13:43 ET
Sector Update: Health Care Stocks Mixed Premarket Thursday
Health care stocks were narrowly mixed premarket Thursday with the Health Care Select Sector SPDR Fund (XLV) marginally higher and the iShares Biotechnology ETF (IBB) fractionally lower. Walgreens Boo
MT NewswiresJun 27 09:18 ET
Kala Pharmaceuticals to Sell 1.197M Shares at $5.85 in Private Placement
Seeking AlphaJun 27 09:06 ET
Express News | KALA BIO Shares Are Trading Higher. The Company Announced a $12.5 Million Private Placement
BenzingaJun 27 08:51 ET

Comments

Jaguar8

Jun 28 15:17

Baker Bros. Advisors LP Reports 19.99% Stake in KALA BIO Inc as of June 26- SEC Filing

$KALA BIO(KALA.US)$

Stock Region

Jun 28 11:20

Biopharmaceutical Company Announces Massive $12.5 Million Private Placement

KALA BIO Announces $12.5 Million Private Placement.
KALA BIO, Inc. (NASDAQ: KALA), a biopharmaceutical company at the clinical stage, has recently disclosed a development involving a new securities purchase agreement. This agreement has been made with a select group of institutional accredited investors and involves the private placement of shares of its common stock and Series H Convertible Non-Redeemable Preferred Stock...